| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | J Philip McCoy | |
| Michael A Solomon | |||
| Sameena S Khan | |||
| P2860 | cites work | Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells | Q24672061 |
| Angiogenesis in cancer and other diseases | Q27861015 | ||
| Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration | Q28207902 | ||
| Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI) | Q28216990 | ||
| Isolation of putative progenitor endothelial cells for angiogenesis | Q28302884 | ||
| Effects of Ginkgo biloba extract on number and activity of endothelial progenitor cells from peripheral blood | Q33201349 | ||
| Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization | Q33606829 | ||
| Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization | Q33870103 | ||
| Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. | Q34286784 | ||
| A review of angiogenesis and anti-angiogenic therapy in hematologic malignancies | Q34532782 | ||
| Phenotypic overlap between hematopoietic cells with suggested angioblastic potential and vascular endothelial cells | Q34532801 | ||
| Endothelial progenitor cells: regulation and contribution to adult neovascularization | Q35002492 | ||
| Endothelial progenitor cells: new hope for a broken heart | Q35160551 | ||
| Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised cl | Q40525372 | ||
| Donor-derived circulating endothelial cells after kidney transplantation | Q40687629 | ||
| Circulating endothelial precursors: mystery, reality, and promise | Q40741679 | ||
| Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells | Q42498432 | ||
| Circulating activated endothelial cells in systemic lupus erythematosus: further evidence for diffuse vasculopathy | Q43607198 | ||
| Mobilization of endothelial progenitor cells in patients with acute myocardial infarction | Q43636896 | ||
| Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease | Q43645304 | ||
| Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells. | Q43808485 | ||
| Hybrid cell-gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells | Q44497559 | ||
| Elevated numbers of circulating endothelial cells in renal transplant recipients. | Q44514900 | ||
| Use of blood outgrowth endothelial cells for gene therapy for hemophilia A. | Q45882442 | ||
| Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. | Q47398233 | ||
| Circulating endothelial cells in patients with septic shock. | Q51365961 | ||
| A mathematical model of the contribution of endothelial progenitor cells to angiogenesis in tumors: implications for antiangiogenic therapy. | Q52015941 | ||
| VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells | Q57382170 | ||
| Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization | Q58816341 | ||
| The Effects of Exercise Training on Markers of Endothelial Function in Young Healthy Men | Q60633005 | ||
| Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis | Q62395188 | ||
| Cytofluorometric detection of human endothelial cells in whole blood using S-Endo 1 monoclonal antibody | Q70169676 | ||
| Circulating endothelial cells in Kawasaki disease | Q73047133 | ||
| Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors | Q73075799 | ||
| Circulating endothelial cells as a novel marker of angiogenesis | Q73212055 | ||
| Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia | Q73395331 | ||
| Circulating activated endothelial cells in sickle cell anemia | Q73884398 | ||
| Resting and activated endothelial cells are increased in the peripheral blood of cancer patients | Q73919503 | ||
| Increased circulating activated endothelial cells, vascular endothelial growth factor, and tumor necrosis factor in thalassemia | Q74447417 | ||
| Circulating endothelial cells as markers for ANCA-associated small-vessel vasculitis | Q78840682 | ||
| Circulating endothelial cells in pulmonary hypertension | Q79092357 | ||
| Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients | Q79370331 | ||
| P4510 | describes a project that uses | flow cytometry | Q1141429 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| flow cytometry | Q1141429 | ||
| P304 | page(s) | 1-8 | |
| P577 | publication date | 2005-03-01 | |
| P1433 | published in | Cytometry Part B: Clinical Cytometry | Q15764840 |
| P1476 | title | Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. | |
| P478 | volume | 64 |
| Q41961052 | A Phase I Clinical, Pharmacokinetic, and Pharmacodynamic Study of Weekly or Every Three Week Ixabepilone and Daily Sunitinib in Patients with Advanced Solid Tumors |
| Q64261464 | A genetic variant associated with multiple sclerosis inversely affects the expression of CD58 and microRNA-548ac from the same gene |
| Q33738574 | A high-yield isolation and enrichment strategy for human lung microvascular endothelial cells |
| Q48120540 | A longitudinal study of maternal endothelial function, inflammatory response and uterine artery blood flow during the second half of pregnancy. |
| Q34183354 | A new approach for rapid and reliable enumeration of circulating endothelial cells in patients. |
| Q79644417 | A phase 1 trial of 2 dose schedules of ABT-510, an antiangiogenic, thrombospondin-1-mimetic peptide, in patients with advanced cancer |
| Q36495915 | A phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin lymphoma: Southwest oncology group study S0108. |
| Q46165524 | A six-colour flow cytometric method for simultaneous detection of cell phenotype and apoptosis of circulating endothelial cells. |
| Q21093355 | A unique population of effector memory lymphocytes identified by CD146 having a distinct immunophenotypic and genomic profile |
| Q51474863 | Abnormal correlation of circulating endothelial progenitor cells and endothelin-1 concentration may contribute to the development of arterial hypertension in childhood acute lymphoblastic leukemia survivors. |
| Q35905581 | Absence of Correlation between Changes in the Number of Endothelial Progenitor Cell Subsets |
| Q33888658 | Acetylsalicylate reduces endothelial and platelet-derived microparticles in patients with coronary artery disease |
| Q40362496 | Addition of aspirin to a fish oil-rich diet decreases inflammation and atherosclerosis in ApoE-null mice |
| Q37150166 | Alterations of circulating bone marrow-derived VEGFR-2+ progenitor cells in isolated limb perfusion with or without rhTNF-α. |
| Q63915163 | An optimized flow cytometry protocol for analysis of angiogenic monocytes and endothelial progenitor cells in peripheral blood |
| Q42466000 | Antagonism of Ang-Tie2 and Dll4-Notch signaling has opposing effects on tumor endothelial cell proliferation, evidenced by a new flow cytometry method |
| Q34097326 | Application of polychromatic flow cytometry to identify novel subsets of circulating cells with angiogenic potential |
| Q37980252 | Are endothelial progenitor cells a prognostic factor in patients with heart failure? |
| Q53137736 | Arterial erectile dysfunction: reliability of new markers of endothelial dysfunction. |
| Q46705818 | Assessment of the potential of progenitor stem cells extracted from human peripheral blood for seeding a novel vascular graft material. |
| Q34630397 | Association of colony-forming units with coronary artery and abdominal aortic calcification |
| Q35168107 | Biology and flow cytometry of proangiogenic hematopoietic progenitors cells |
| Q60935302 | Blood Outgrowth and Proliferation of Endothelial Colony Forming Cells are Related to Markers of Disease Severity in Patients with Pulmonary Arterial Hypertension |
| Q35244383 | CD144, CD146 and VEGFR-2 properly identify circulating endothelial cell |
| Q90399249 | CD146 T cells in lung cancer: its function, detection, and clinical implications as a biomarker and therapeutic target |
| Q46213211 | CD146, a novel target of CD44-signaling, suppresses breast tumor cell invasion |
| Q37279639 | Cell therapy in peripheral arterial disease |
| Q33270316 | Cells meeting our immunophenotypic criteria of endothelial cells are large platelets |
| Q43427303 | Characterization and comparison of bone marrow and peripheral blood mononuclear cells used for cellular therapy in critical leg ischaemia: towards a new cellular product |
| Q37299872 | Circulating and imaging markers for angiogenesis. |
| Q34469305 | Circulating angiogenic cells can be derived from cryopreserved peripheral blood mononuclear cells |
| Q37463927 | Circulating biomarkers for vascular endothelial growth factor inhibitors in renal cell carcinoma |
| Q26823035 | Circulating biomarkers of response to sunitinib in gastroenteropancreatic neuroendocrine tumors: current data and clinical outlook |
| Q38221884 | Circulating endothelial cells and chronic kidney disease |
| Q48018929 | Circulating endothelial cells and their apoptotic fraction are mutually independent predictive biomarkers in Bevacizumab-based treatment for advanced colorectal cancer. |
| Q38672972 | Circulating endothelial cells and their subsets: novel biomarkers for cancer. |
| Q36429640 | Circulating endothelial cells in malignant disease |
| Q48466945 | Circulating endothelial cells in obstructive sleep apnea: an important methodological lesson |
| Q35067553 | Circulating endothelial cells in patients with venous thromboembolism and myeloproliferative neoplasms |
| Q61960663 | Circulating endothelial cells in whole blood donations and the effect of leucodepletion |
| Q36447619 | Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer |
| Q58710680 | Circulating endothelial progenitor cells and endothelial cells in moyamoya disease |
| Q83233981 | Circulating endothelial progenitor cells are reduced in SLE in the absence of coronary artery calcification |
| Q33357429 | Circulating endothelial progenitor cells as a predictor of response to cardiac resynchronization therapy: the missing piece of the puzzle? |
| Q37203258 | Circulating endothelial progenitor cells in cerebrovascular disease |
| Q37249340 | Circulating progenitor and mature endothelial cells in deep vein thrombosis |
| Q85157317 | Clinical Characteristics of Patients With Kawasaki Disease and Levels of Peripheral Endothelial Progenitor Cells and Blood Monocyte Subpopulations |
| Q39146799 | Clinical significance of CD146 and latexin during different stages of thyroid cancer |
| Q36224188 | Continuous administration of recombinant human endostatin (Endostar): A pre-clinical safety study |
| Q51229659 | Correlation between increased circulating endothelial progenitor cells and stage of non-Hodgkin lymphoma. |
| Q33765564 | Correlations between angiogenic factors and capillaroscopic patterns in systemic sclerosis |
| Q34322794 | Cryopreservation and Enumeration of Human Endothelial Progenitor and Endothelial Cells for Clinical Trials |
| Q46630491 | Dare to date: age estimation of subdural hematomas, literature, and case analysis |
| Q53061032 | Detection and Characterization of Rare Circulating Endothelial Cells by Imaging Flow Cytometry. |
| Q39965440 | Detection and characterization of circulating endothelial progenitor cells in normal rat blood |
| Q40952760 | Development of a Modular Assay for Detailed Immunophenotyping of Peripheral Human Whole Blood Samples by Multicolor Flow Cytometry |
| Q37732473 | Dielectrophoresis for Biomedical Sciences Applications: A Review |
| Q37283390 | Differential CD146 expression on circulating versus tissue endothelial cells in rectal cancer patients: implications for circulating endothelial and progenitor cells as biomarkers for antiangiogenic therapy |
| Q33323355 | Direct isolation, culture and transplant of mouse skeletal muscle derived endothelial cells with angiogenic potential |
| Q35444368 | Discrimination between circulating endothelial cells and blood cell populations with overlapping phenotype reveals distinct regulation and predictive potential in cancer therapy. |
| Q64237401 | Early risk assessment of circulating endothelial progenitor cells and plasma stromal cell-derived factor-1 for nondisabling ischemic cerebrovascular events |
| Q53563103 | Effect of acute exercise on endothelial progenitor cells in patients with peripheral arterial disease. |
| Q33813731 | Effects of immunoadsorption on endothelial function, circulating endothelial progenitor cells and circulating microparticles in patients with inflammatory dilated cardiomyopathy |
| Q31050181 | Effects of recombinant human endostatin and its synergy with cisplatin on circulating endothelial cells and tumor vascular normalization in A549 xenograft murine model |
| Q38780346 | Endothelial progenitor cell number is not decreased in 34 children with Juvenile Dermatomyositis: a pilot study |
| Q84959547 | Endothelial progenitor cells are associated with response to chemotherapy in human non-small-cell lung cancer |
| Q50765552 | Endothelial progenitor cells as a biological marker of peripheral artery disease. |
| Q36011477 | Endothelial progenitor cells in atherosclerosis |
| Q35774189 | Endothelial progenitor cells in cardiovascular disease and chronic inflammation: from biomarker to therapeutic agent |
| Q35604291 | Endothelial progenitor cells in cardiovascular diseases: from biomarker to therapeutic agent |
| Q36084953 | Endothelial progenitor cells: a new player in lupus? |
| Q28303395 | Endothelial progenitor cells: identity defined? |
| Q26991693 | Endothelial-binding, proinflammatory T cells identified by MCAM (CD146) expression: Characterization and role in human autoimmune diseases |
| Q34193750 | Enrichment of outgrowth endothelial cells in high and low colony-forming cultures from peripheral blood progenitors |
| Q41337005 | Enumeration of circulating endothelial cell frequency as a diagnostic marker in aortic valve surgery - a flow cytometric approach |
| Q83454274 | Expression of receptor for advanced glycation end products (RAGE) on the surface of circulating endothelial cells is upregulated in Kawasaki disease |
| Q81827310 | Flow cytometric assessment of monocyte activation markers and circulating endothelial cells in patients with localized or metastatic breast cancer |
| Q34250011 | Flow cytometric identification and functional characterization of immature and mature circulating endothelial cells |
| Q46926506 | Flow cytometric measurement of circulating endothelial cells: the effect of age and peripheral arterial disease on baseline levels of mature and progenitor populations |
| Q35842591 | Galectin-3 deficiency exacerbates hyperglycemia and the endothelial response to diabetes |
| Q34152945 | Gene expression profiling in circulating endothelial cells from systemic sclerosis patients shows an altered control of apoptosis and angiogenesis that is modified by iloprost infusion |
| Q79832164 | Hormonal status modulates circulating endothelial progenitor cells |
| Q38023863 | Human endothelial progenitor cells |
| Q34647525 | Imaging flow cytometry for morphologic and phenotypic characterization of rare circulating endothelial cells |
| Q53509755 | Immunophenotypic, cytogenetic and functional characterization of circulating endothelial cells in myelodysplastic syndromes. |
| Q41069524 | Improving the characterization of endothelial progenitor cell subsets by an optimized FACS protocol. |
| Q34586902 | In vitro characterization of circulating endothelial progenitor cells isolated from patients with acute coronary syndrome |
| Q37806059 | In vitro models for the evaluation of angiogenic potential in bone engineering |
| Q38234984 | In vitro pre-vascularisation of tissue-engineered constructs A co-culture perspective |
| Q50349915 | Incremental increase in VEGFR1⁺ hematopoietic progenitor cells and VEGFR2⁺ endothelial progenitor cells predicts relapse and lack of tumor response in breast cancer patients |
| Q57805880 | Intrinsic Vascular Repair by Endothelial Progenitor Cells in Acute Coronary Syndromes: an Update Overview |
| Q30770612 | Isolation and characterization of circulating lymphatic endothelial colony forming cells |
| Q46350318 | Low levels of endothelial progenitor cells and their association with systemic inflammation and monocyte activation in older HIV-infected men. |
| Q61845341 | Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in preeclampsia and small for gestational age |
| Q36015213 | Low-dose estradiol and endothelial and inflammatory biomarkers in menopausal overweight/obese women |
| Q36362162 | Microvascular Function and Endothelial Progenitor Cells in Patients with Severe Hypercholesterolemia and the Familial Hypercholesterolemia Phenotype |
| Q49935863 | Mobilization of endothelial progenitor cell in patients with acute ischemic stroke |
| Q33293918 | Neonatal lung side population cells demonstrate endothelial potential and are altered in response to hyperoxia-induced lung simplification |
| Q30525599 | Nestin- and doublecortin-positive cells reside in adult spinal cord meninges and participate in injury-induced parenchymal reaction. |
| Q41853746 | Novel stem/progenitor cells with neuronal differentiation potential reside in the leptomeningeal niche |
| Q37267758 | Personalized cytomic assessment of vascular health: Evaluation of the vascular health profile in diabetes mellitus |
| Q37407066 | Phase II study of bevacizumab in combination with sorafenib in recurrent glioblastoma (N0776): a north central cancer treatment group trial |
| Q42857353 | Pilot study to relate clinical outcome in pancreatic carcinoma and angiogenic plasma factors/circulating mature/progenitor endothelial cells: Preliminary results. |
| Q33883127 | Pregnancy-induced hypertension is accompanied by decreased number of circulating endothelial cells and circulating endothelial progenitor cells |
| Q36839005 | Promise of endothelial progenitor cell for treatment of diabetic retinopathy |
| Q46196670 | Putative endothelial progenitor cells are associated with flow-mediated dilation in refractory hypertensives |
| Q33364588 | Quantification of circulating endothelial and progenitor cells: comparison of quantitative PCR and four-channel flow cytometry |
| Q30418365 | Rare cell isolation and analysis in microfluidics |
| Q34703187 | Reduced circulating endothelial progenitor cells in reversible cerebral vasoconstriction syndrome |
| Q33847880 | Reduced levels of circulating endothelial progenitor cells in acute myocardial infarction patients with diabetes or pre-diabetes: accompanying the glycemic continuum. |
| Q39316792 | Separation of two phenotypically similar cell types via a single common marker in microfluidic channels |
| Q37400965 | Soluble and membranous vascular endothelial growth factor receptor-2 in pregnancies complicated by pre-eclampsia |
| Q38992916 | Subclinical vascular endothelial dysfunctions and myocardial changes with type 1 diabetes mellitus in children and adolescents. |
| Q90692481 | The Blood Circulating Rare Cell Population. What is it and What is it Good For? |
| Q28302998 | The ever-elusive endothelial progenitor cell: identities, functions and clinical implications |
| Q35700414 | The inflammation, vascular repair and injury responses to exercise in fit males with and without Type 1 diabetes: an observational study. |
| Q30416353 | The intersection of flow cytometry with microfluidics and microfabrication |
| Q50559926 | Type 2 diabetes mellitus impairs the maturation of endothelial progenitor cells and increases the number of circulating endothelial cells in peripheral blood. |
| Q40324178 | Vascular Health Profile predicts cardiovascular outcomes in patients with diabetes |
| Q61928245 | p-Cresol and Cardiovascular Risk in Kidney Transplant Recipients |
Search more.